Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700001G01Rik Activators

1700001G01Rik activators consist of a diverse array of chemical compounds, each participating in unique signaling pathways to augment the function of 1700001G01Rik. For instance, Forskolin, by increasing intracellular cAMP levels, might indirectly enhance 1700001G01Rik activity through cAMP-dependent protein kinases that phosphorylate proteins in proximity to or in direct interaction with 1700001G01Rik. Similarly, PMA engages protein kinase C, which may phosphorylate partners of 1700001G01Rik, leading to an enhancement of its activity. The calcium ionophores Ionomycin and A23187 raise intracellularcalcium levels, which in turn could activate calcium-dependent kinases that affect 1700001G01Rik function either by direct phosphorylation or through phosphorylation of associated proteins. Epigallocatechin gallate (EGCG) serves as a kinase inhibitor that may relieve inhibitory phosphorylation controls on 1700001G01Rik, thereby potentiating its activity. Additionally, Sphingosine-1-phosphate potentially activates pathways involving kinases that could phosphorylate and thereby activate 1700001G01Rik or its interacting partners.

In parallel, the PI3K inhibitors LY294002 and Wortmannin could indirectly enhance 1700001G01Rik activity by shifting cellular signaling towards pathways that activate 1700001G01Rik when PI3K is inhibited. U0126 and SB203580, by inhibiting MEK1/2 and p38 MAPK respectively, might also cause a signaling reroute that favors 1700001G01Rik activation. Thapsigargin further contributes to this network by disrupting calcium homeostasis, thus stimulating calcium-dependent signaling which might intersect with pathways influencing 1700001G01Rik activity. Lastly, Genistein, through tyrosine kinase inhibition, could reduce competitive phosphorylation, thereby freeing pathways to enhance 1700001G01Rik's activity. Collectively, these compounds influence distinct but interconnected signaling pathways that converge to enhance the functional activity of 1700001G01Rik, demonstrating the complexity and interconnectedness of intracellular signaling and its impact on specific protein functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of substrates that may include proteins interacting with or regulating 1700001G01Rik, thereby enhancing its activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin functions as a calcium ionophore, raising intracellular calcium levels. Elevated calcium may activate calcium-dependent kinases, which can modulate the function of 1700001G01Rik by altering its phosphorylation state or interaction with binding partners.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is a kinase inhibitor that could inhibit kinases that normally phosphorylate inhibitors of 1700001G01Rik. This could lead to a reduction in inhibitory control and thus enhance the activity of 1700001G01Rik.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which may lead to downstream signaling cascades involving kinases that phosphorylate and activate proteins that interact with 1700001G01Rik, enhancing its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can lead to a compensatory response that enhances the activity of alternative signaling pathways, potentially including those that activate 1700001G01Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK could shift signaling dynamics in the cell, leading to the activation of compensatory pathways that enhance the activity of 1700001G01Rik.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 acts as a calcium ionophore, similar to ionomycin, and enhances intracellular calcium, which can activate calcium-dependent signaling pathways potentially linked to the activation of 1700001G01Rik.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels which may activate signaling pathways that enhance 1700001G01Rik activity through calcium-dependent phosphorylation.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein acts as a tyrosine kinase inhibitor, which may reduce competitive phosphorylation events and thereby enhance signaling pathways that activate 1700001G01Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor that, like LY294002, may enhance the activity of 1700001G01Rik through the activation of compensatory signaling pathways when PI3K is inhibited.